New bladder cancer treatment tracked in Real-World study
NCT ID NCT07309445
First seen Jan 08, 2026 · Last updated May 07, 2026 · Updated 17 times
Summary
This study looks at how well TAR-200 works for people with early-stage bladder cancer (NMIBC) in real-world settings. Researchers will measure how long it takes for the cancer to come back or get worse after starting TAR-200. About 150 participants who have already started TAR-200 will be followed over time. The goal is to understand the treatment's effectiveness outside of controlled clinical trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-MUSCLE INVASIVE BLADDER NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Arkansas Urology
RECRUITINGLittle Rock, Arkansas, 72211, United States
Conditions
Explore the condition pages connected to this study.